FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

MOONLAKE IMMUNOTHERAPEUTICS: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-03-31Status: supersededProvenance attached

Cite: FACTANKER, https://factanker.com/fact/320f8c66-d6f3-40f3-a621-74c1410d004b

Reported value

$150.000k{"amount": 150000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
MOONLAKE IMMUNOTHERAPEUTICS
Metric
cashflow_financing
Period
2022-01-01 – 2022-03-31
Status
superseded
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001213900-22-027086 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:19:56.383138+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001821586/cashflow-financing/2022-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.